plumbagin has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranoski, A; Biazi, BI; Coatti, GC; Corveloni, AC; Lepri, SR; Mancilla, IA; Mantovani, MS; Marques, LA; Zanetti, TA | 1 |
| Chang, CH; Che, D; Chen, ZJ; Ding, Y; Liu, S; Vetter, M | 1 |
2 other study(ies) available for plumbagin and Kidney Neoplasms
| Article | Year |
|---|---|
Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Kidney Neoplasms; Naphthoquinones; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phytochemicals; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Humans; Kidney Neoplasms; NAD; NADP; NADPH Oxidase 4; NADPH Oxidases; Naphthoquinones; Onium Compounds; Plumbaginaceae; Transfection | 2005 |